Literature DB >> 2701939

Nucleotide sequences of influenza A virus RNA segment 7: a comparison of five isolates.

S L Zebedee1, R A Lamb.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2701939      PMCID: PMC317678          DOI: 10.1093/nar/17.7.2870

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  3 in total

1.  Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins.

Authors:  R A Lamb; C J Lai; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

2.  Conservation of the influenza virus membrane protein (M1) amino acid sequence and an open reading frame of RNA segment 7 encoding a second protein (M2) in H1N1 and H3N2 strains.

Authors:  R A Lamb; C J Lai
Journal:  Virology       Date:  1981-07-30       Impact factor: 3.616

3.  Nucleotide sequence coding for the "signal peptide" and N terminus of the hemagglutinin from an asian (H2N2) strain of influenza virus.

Authors:  G M Air
Journal:  Virology       Date:  1979-09       Impact factor: 3.616

  3 in total
  15 in total

1.  Residue 41 of the Eurasian avian-like swine influenza a virus matrix protein modulates virion filament length and efficiency of contact transmission.

Authors:  Patricia J Campbell; Constantinos S Kyriakis; Nicolle Marshall; Suganthi Suppiah; Jill Seladi-Schulman; Shamika Danzy; Anice C Lowen; John Steel
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

2.  Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block.

Authors:  C Wang; K Takeuchi; L H Pinto; R A Lamb
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

Review 3.  Virulence of influenza A virus for mouse lung.

Authors:  A C Ward
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

4.  The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging.

Authors:  Matthew F McCown; Andrew Pekosz
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.

Authors:  Yu-Na Lee; Young-Tae Lee; Min-Chul Kim; Andrew T Gewirtz; Sang-Moo Kang
Journal:  J Immunol       Date:  2016-02-10       Impact factor: 5.422

6.  Specific changes in the M1 protein during adaptation of influenza virus to mouse.

Authors:  A C Ward
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

Review 7.  Use of hepadnavirus core proteins as vaccine platforms.

Authors:  David C Whitacre; Byung O Lee; David R Milich
Journal:  Expert Rev Vaccines       Date:  2009-11       Impact factor: 5.217

8.  Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins.

Authors:  T Ito; O T Gorman; Y Kawaoka; W J Bean; R G Webster
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

9.  Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets.

Authors:  Nedzad Music; Adrian J Reber; Min-Chul Kim; Ian A York; Sang-Moo Kang
Journal:  Vaccine       Date:  2015-12-19       Impact factor: 3.641

Review 10.  An Antigenic Thrift-Based Approach to Influenza Vaccine Design.

Authors:  Jai S Bolton; Hannah Klim; Judith Wellens; Matthew Edmans; Uri Obolski; Craig P Thompson
Journal:  Vaccines (Basel)       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.